Anxiety, Depression, Psoriasis, Stress, Psychological
Conditions
Brief summary
Two mind-relaxing techniques will be applied to psoriasis patients with an elevated psychological stress profile at baseline
Interventions
BEHAVIORALPsychological stress relief techniques
Psychological stress relief techniques
Sponsors
Grigore T. Popa University of Medicine and Pharmacy
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* clinical diagnosis of psoriasis * adequate psychological stress profile * access to a personal computer/ laptop/ smartphone with internet connection * agreement to the informed consent form
Exclusion criteria
* other dermatological conditions which impair the life quality * psychological disorders under psychiatric treatment * hearing impairment * other on-going medical studies * pregnancy * aliteracy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient Health Questionnaire-9 | 6 months | Patient Health Questionnaire-9 will be applied at baseline, 1 month and 6 months. Patient Health Questionnaire-9 minimum score = 0 (no depression) Patient Health Questionnaire-9 maximum score = 27 (maximum depression) |
| Dermatological Life Quality Index | 6 months | Dermatological Life Quality Index Score will be calculated at baseline, 1 month and 6 months. Dermatological Life Quality Index minimum score = 0 (no impairment of life quality) Dermatological Life Quality Index maximum score = 30 (maximum impairment of life quality) |
| Psychological stress | 6 months | A visual analog scale will be used at baseline, 1 month and 6 months. Analog scale minimum value = 0 (no stress) Analog scale maximum value = 10 (maximum stress) |
| General Anxiety Disorder-7 | 6 months | General Anxiety Disorder-7 questionnaire will be applied at baseline, 1 month and 6 months. General anxiety disorded-7 minimum score = 0 (no anxiety) General anxiety disorded-7 maximum score = 21 (maximum anxiety) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Psoriasis Area and Severity Index | 6 months | Psoriasis Area and Severity Index score will be calculated will be applied at baseline, 1 month and 6 months. Psoriasis Area and Severity Index minimum score = 0 (no severity - no lesions) Psoriasis Area and Severity Index maximum score = 72 (maximum severity) |
| Self Administered Psoriasis Area and Severity Index | 6 months | The self Administered Psoriasis Area and Severity Index score will be calculated by the patient at baseline, 1 month and 6 months. The self Administered Psoriasis Area and Severity Index minimum score = 0 (no severity - no lesions) The self Administered Psoriasis Area and Severity Index maximum score = 72 (maximum severity) |
| The Revised Illness Perception Questionnaire | 6 months | The Revised Illness Perception Questionnaire will be applied at baseline, 1 month and 6 months. The Revised Illness Perception Questionnaire minimum score = 0 (best illness perception) The Revised Illness Perception Questionnaire maximum score = 80 (worst illness perception) |
| Dermatological treatment compliance | 6 months | A visual analog scale will be applied at baseline, 1 month and 6 months. Analog scale minimum value = 0 (total lack of compliance) Analog scale maximum value = 10 (maximum compliance) |
Countries
Romania
Contacts
Primary ContactBogdan-Marian Tarcau
Outcome results
None listed